Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency

Cited by (347)

Items 301–347 of 347

1. Evaluación in vitro de la actividad citotóxica de los extractos de Malachra alceifolia Jacq, Cordia dentata Poir Heliotropium indicum Linn sobre la linea celular de Osteosarcoma OSCA-8
   Erika Johana Lozano Aguilar, Karen Alejandra Reyes Álvarez · 2019
2. Genomic and proteomic profiling of osteosarcoma
   Ana Patiño‐García, Fernando Lecanda · 2021 · Elsevier eBooks
3. Faculty Opinions recommendation of Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group.
   Nathalie Gaspar · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
4. Caracterização de alterações genômicas caóticas em osteossarcoma
   Alexandra Galvão Gomes · 2020 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
5. Bone Tumours
   Stefan Bielack, Michael Paulussen, Lee J. Helman · 2020 · Oxford University Press eBooks
6. miR-486 Expression is Regulated by DNA Methylation in Osteosarcoma
   Heidi Maria Namløs, Magne Skårn, Deeqa Ahmed, Iwona Grad, Kim Andresen, Stine H. Kresse, Massimo Serra, Katia Scotlandi, Antonio Llombart‐Bosch, Ola Myklebost et al. · 2020 · Research Square
7. Molecular genetics of bone tumors
   Narasimhan P. Agaram · 2022 · Diagnostic histopathology
8. Malignant Bone-Forming Tumors
   2021 · American Registry of PathologyArlington, Virginia eBooks
9. Genetics of Bone Tumors
   2021 · American Registry of PathologyArlington, Virginia eBooks
10. Data from Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining
    Qin Zhou, Michelle E. Howard, Xinyi Tu, Qian Zhu, Janet M. Denbeigh, Nicholas B. Remmes, Michael Herman, Chris J Beltran, Jian Yuan, Patricia Theresa Greipp et al. · 2023
11. Data from Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining
    Qin Zhou, Michelle E. Howard, Xinyi Tu, Qian Zhu, Janet M. Denbeigh, Nicholas B. Remmes, Michael Herman, Chris J Beltran, Jian Yuan, Patricia Theresa Greipp et al. · 2023
12. Data from Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at Diagnosis
    Antonin Marchais, Maria Eugénia Marques Da Costa, Bastien Job, Rachid Abbas, Damien Drubay, Sophie Piperno-Neumann, Olivia Fromigué, Anne Gomez‐Brouchet, Françoise Rédiní, Robin Droit et al. · 2023
13. Data from SETD2 Is Recurrently Mutated in Whole-Exome Sequenced Canine Osteosarcoma
    Sharadha Sakthikumar, Ingegerd Elvers, Jaegil Kim, Maja L. Arendt, Rachael J. Thomas, Jason Turner-Maier, Ross Swofford, Jeremy Johnson, Steven E. Schumacher, Jessica Alföldi et al. · 2023
14. Data from Alterations in BAP1 Are Associated with Cisplatin Resistance through Inhibition of Apoptosis in Malignant Pleural Mesothelioma
    Kathrin Oehl, Bart Vrugt, Ulrich Wagner, Michaela B. Kirschner, Mayura Meerang, Walter Weder, Emanuela Felley‐Bosco, Bernd Wollscheid, Katrin Bankov, Melanie C Demes et al. · 2023
15. Data from SLFN11 is Widely Expressed in Pediatric Sarcoma and Induces Variable Sensitization to Replicative Stress Caused By DNA-Damaging Agents
    Jessica Gartrell, Marcia Mellado-Largarde, Michael R. Clay, Armita Bahrami, Natasha A. Sahr, April D. Sykes, Kaley Blankenship, Lauren Hoffmann, Jia Xie, Hyekyung P. Cho et al. · 2023
16. The role of ATRX in neuroblastoma
    Michael R. van Gerven · 2023
17. Utilidad de los estudios genómicos basados en paneles de NGS (Next Generation Sequencing) para el manejo clínico de los sarcomas en pacientes pediátricos
    Miriam Gutiérrez · 2023
18. Current status and future directions of systemic therapy in high-grade bone sarcomas
    Gennady N. Machak · 2024 · N N Priorov Journal of Traumatology and Orthopedics
19. Osteosarcoma in an Adolescent With Germline DYNC1H1 ‐Related Disorder: A Novel Association With Whole Genome and Transcriptome Tumour Analysis
    Cameron J. Grisdale, Rachel V. Silverberg, Bilal M. Marwa, Trevor J. Loback, Alysa A. Poulin, Kaveer K. Chatoorgoon, Saima Alvi, Shahrad Rod Rassekh, Rebecca J. Deyell, Paul R. D'Alessandro · 2025 · Pediatric Blood & Cancer
20. Case Report: BRCA1 and BRCA2 loss in a young man with primary cutaneous extraskeletal osteosarcoma
    Wenfeng Luo, Yu-Hang Hou, Yu-Teng Huang, Jun‐Dong Lai, Hui-Shan Jiang, Wei-Liang Wang · 2025 · Frontiers in Oncology
21. Non-Coding RNAs in Diagnostic Pathology of High-Grade Central Osteosarcoma
    Albert Roessner, Sabine Franke, Julian Schreier, Sarah Rebecca Ullmann, Franziska Karras · 2025 · Diagnostics
22. Additional file 1 of Pan-cancer detection of driver genes at the single-patient resolution
    Joel Nulsen, Hrvoje Mišetić, Christopher Yau, Francesca D. Ciccarelli · 2021 · Figshare
23. Additional file 3 of SOX9 is a key component of RUNX2-regulated transcriptional circuitry in osteosarcoma
    Kim, Young-Im, Tseng, Yu-Chou, Gamze Ayaz, Shasha Wang, Hualong Yan, Wendy Dubois, Yang, Howard, Tao Zhen, Lee, Maxwell P., Liu, Paul et al. · 2024 · Figshare
24. Additional file 1 of SOX9 is a key component of RUNX2-regulated transcriptional circuitry in osteosarcoma
    Kim, Young-Im, Tseng, Yu-Chou, Gamze Ayaz, Shasha Wang, Hualong Yan, Wendy Dubois, Yang, Howard, Tao Zhen, Lee, Maxwell P., Liu, Paul et al. · 2024 · Figshare
25. Additional file 5 of SOX9 is a key component of RUNX2-regulated transcriptional circuitry in osteosarcoma
    Kim, Young-Im, Tseng, Yu-Chou, Gamze Ayaz, Shasha Wang, Hualong Yan, Wendy Dubois, Yang, Howard, Tao Zhen, Lee, Maxwell P., Liu, Paul et al. · 2024 · Figshare
26. Additional file 2 of SOX9 is a key component of RUNX2-regulated transcriptional circuitry in osteosarcoma
    Kim, Young-Im, Tseng, Yu-Chou, Gamze Ayaz, Shasha Wang, Hualong Yan, Wendy Dubois, Yang, Howard, Tao Zhen, Lee, Maxwell P., Liu, Paul et al. · 2023 · Figshare
27. Additional file 4 of SOX9 is a key component of RUNX2-regulated transcriptional circuitry in osteosarcoma
    Kim, Young-Im, Tseng, Yu-Chou, Gamze Ayaz, Shasha Wang, Hualong Yan, Wendy Dubois, Yang, Howard, Tao Zhen, Lee, Maxwell P., Liu, Paul et al. · 2024 · Figshare
28. Age-dependent chromosomal instability in osteosarcoma: younger patients exhibit paradoxically higher genomic damage
    Tiara S. Jamison · 2026 · Research Square
29. ATRX one site mutation in 3’UTR enhanced the interaction between miR-25-3p and relates to carcinogenesis of osteosarcoma
    Chun Yin, Bin Fang, Zi Li, Haitao Sun, Sheng Wei · 2026 · Gene Reports
30. Mécanismes épigénétiques associés à la progression et à la chimiorésistance des sarcomes osseux
    Camille Jacques · 2016 · theses.fr (ABES)
31. Ciblage thérapeutique de la réponse au stress cellulaire dans l'ostéosarcome
    Brice Moukengué · 2019 · theses.fr (ABES)
32. Impact du microenvironnement et de la vascularisation tumorale dans la réponse de l’ostéosarcome à la chimiothérapie
    Vincent Crenn · 2021 · theses.fr (ABES)
33. Activation du mécanisme ALTernatif de maintenance des télomères dans les ostéosarcomes de haut grade
    Alexandre Tassin de Nonneville · 2021 · theses.fr (ABES)
34. Caractérisation des cellules tumorales circulantes de sarcomes osseux : identification de nouveaux marqueurs de la pathologie recidivante
    Antoine Chalopin · 2022 · theses.fr (ABES)
35. DNA damage-induced nuclear envelope rupture : A new cancer vulnerability
    Marton Kovacs · 2023 · theses.fr (ABES)
36. Calpain-dependent antigen processing generates a tumor-associated epitope recognized by osteosarcoma-infiltrating T cells
    Takahide Itabashi, Tomoyuki Minowa, Makoto Emori, Akiko Minami, Yuka Mizue, Aiko Murai, Akari Takaya, Hiroko Asanuma, Kenta Sasaki, Rena Morita et al. · 2026 · Research Square
37. Combined Inhibition of ATR and Ribonucleotide Reductase Induces Synergistic Antineoplastic Activity in Osteosarcoma Cells
    Natalie Aderhold, Lisa Immesberger, Sabine Becker, Till Milde, Bernd Gruhn, Jürgen Sonnemann · 2026 · Cancer Reports
38. Advancements and Challenges in Veterinary Oncology
    2026 · Frontiers research topics
39. Liquid biopsy-based monitoring of six biomarker gene copy number variations reveals predictors of progression and treatment resistance in localized soft tissue sarcomas
    Aneta Maria Borkowska, Teresa Szczepińska, Piotr Rutkowski, Michał Sitek, Wiktoria Trynkos, Izabela Ziuzia-Graczyk, Anna Staniszewska, Łukasz Kuryk, Ewelina Holm Bidstrup, Monika Staniszewska · 2026 · Research Square
40. Genomic landscape and tumor immune microenvironment of osteosarcoma: Bridging mechanistic insights to precision therapeutics
    Chenchen Yang, Yiyang Yu, Yaqi Wang, Zhenyu Cai, Yuwei Zhao, Hengyue Ma, Jie Xu, Huaiqiu Zhu, Tingting Ren, Xiaodong Tang et al. · 2026 · Bone Reports
41. KIF18A inhibitor prevents chromosomally unstable osteosarcoma growth by activating spindle assembly checkpoint
    Qiang Yan, Y Zhang, P-F Wang, Yahui Fu, Chao Ke, Shuang Han, Jian Xing, Haoran Li, Kun Zhang · 2026 · Cancer Biology & Therapy
42. Single-cell and longitudinal transcriptomics-guided engineering of FZD1-targeting precision nanotherapy against osteosarcoma cancer stem cells
    Zhiyu Chen, Zimeng Li, Wanli Yu, Huanhuan Huang, Junhong Chen, Yunsheng Jiang, Xu Zhou, Ling Zhong, Hongmei Zhuo, Yukun Jia et al. · 2026 · Bioactive Materials
43. Biomimetic multistage drug delivery system for reversing chemoresistance in osteosarcoma
    Xingyin Li, Shaojie Xu, Youyun Peng, Ziliang Su, Sining Wang, Ang Li, Yaying Du, Zengwu Shao, Xin Huang · 2026 · Chemical Engineering Journal
44. OSTEOSARCOMA: THE MOLECULAR BASIS OF THERAPEUTIC RESISTANCE
    Birupaksha Biswas, Md. Masud Rana, Shovan Konar, Mr Akash Ghosh, Anita Samanta · 2026 · Genetics and Molecular Research
45. Integrated multi-omic analysis of pediatric metastatic osteosarcoma reveals endothelial cell plasticity and lineage infidelity
    Julian Burks, Ying Wu, Krithika Bhuvaneshwar, Neeraja Syed, Dahee Jung, Carly M. Sayers, Demond Williams, Swapna Vidhur Daulatabad, Therry Malone, Julie Galindo et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
46. Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300
    Ian Michael Delahunty, Stephanie Nance, Yang Zhang, François Lamoureux, Qi Liu, William C. Wright, Kristina Ritter, Noha A.M. Shendy, Bénédicte Brounais-Le Royer, Sandra J. Kietlinska et al. · 2026 · The Journal of Experimental Medicine
47. The homologous recombination deficiency status reveals neoadjuvant chemotherapy efficacy and prognosis in Chinese osteosarcoma
    Zhiping Deng, Tao Jin, Li Mingwei, Jing Guo, Yang Sun, Yang Yongkun, Qing Zhang, Jiayue Qin, Feng Lou, Shanbo Cao et al. · 2026 · Therapeutic Advances in Medical Oncology